Skip to main content

Lupus

      RT @RHEUMarampa: Dr. Petri et al: Very ⬇ 25(OH)Vit D levels (<20ng/mL) is associated w/ renal insufficiency in SLE

      sheila RHEUMarampa

      4 years 11 months ago
      Dr. Petri et al: Very ⬇ 25(OH)Vit D levels (<20ng/mL) is associated w/ renal insufficiency in SLE 🚨Levels >60ng/mL can ⬆renal insufficiency This reinforces benefits of Vit.D supplementation (⬇ protnuria; immunomodulation) @RheumNow #ACR20 abs1789 https://t.co/BJciK77fcp
      RT @DrMiniDey: #AerobicExercise improves #Fatigue &amp; #QualityofLife in women w/ #SLE
      - ↓Fatigue &amp; ↑overall he

      Mrinalini Dey DrMiniDey

      4 years 11 months ago
      #AerobicExercise improves #Fatigue & #QualityofLife in women w/ #SLE - ↓Fatigue & ↑overall health after exercise program - No increase in #lupus activity - Data may inform understanding of fatigue & exercise interventions in SLE Abs#1838 #ACR20 @RheumNow https://t.co/0YtYHrWp6t
      Best Practices for APL Testing: Dr. Michelle Petri

      Dr. Jack Cush interviews Dr. Petri about the comparative value of lupus anticoagulant vs. other antiphospholipid antibody tests and their role in CVA or MI - looking at abstracts #1261#1262 and #1266 presented at the 2020 ACR Annual Meeting. 

      RT @RHEUMarampa: Data from Prof. Michelle Petri's study showed double+ or triple+ aPLs were not superior to single LAC+

      sheila RHEUMarampa

      4 years 11 months ago
      Data from Prof. Michelle Petri's study showed double+ or triple+ aPLs were not superior to single LAC+ for risk of thrombosis in #SLE patients. @RheumNow #ACR20 https://t.co/uDHsbd1Y1k
      Blood Brain Barrier Leakage in SLE: Dr. Janet Pope

      Dr. Janet Pope reviews abstract #1508 at the 2020 ACR annual meeting.

      RT @Janetbirdope: After #COVID19 there may be more #LUPUS due to...@RheumNow @CRASCRRheum #ACR20

      Janet Pope Janetbirdope

      4 years 11 months ago
      After #COVID19 there may be more #LUPUS due to...@RheumNow @CRASCRRheum #ACR20
      RT @drpnash: Herpes Zoster Events with Anifrolumab in Patients with Active SLE: An Integrated Analysis of Phase 2 and Ph

      Peter Nash drpnash

      4 years 11 months ago
      Herpes Zoster Events with Anifrolumab in Patients with Active SLE: An Integrated Analysis of Phase 2 and Phase 3 Trials https://t.co/70oOHXihFb #SLE #zoster x 4-5 times increase in zoster
      RT @ejdein1: @jhrheumatology Michelle Petri MD MPH: thrombosis risk composite score = Low C3 + dRVVT + Platelet C4d. Abs

      Eric Dein ejdein1

      4 years 11 months ago
      @jhrheumatology Michelle Petri MD MPH: thrombosis risk composite score = Low C3 + dRVVT + Platelet C4d. Abst#1513. PltC4d associated with proteinuria, venous/arterial thrombosis. #ACR20 @RheumNow https://t.co/OdAjul5Usg
      RT @ejdein1: @andreafava @jhrheumatology shows class switch is common in lupus nephritis biopsy, chronicity scores are c

      Eric Dein ejdein1

      4 years 11 months ago
      @andreafava @jhrheumatology shows class switch is common in lupus nephritis biopsy, chronicity scores are critical. Shows value of need for liquid biopsy @rheumnow #ACR20 Abst#1512 https://t.co/M0DWmTLP29
      RT @uptoTate: Dr. Crow's #StateoftheArt lecture revealed that BEL may be best used in pts with &lt; 2 years and SLEDAI &

      Dr. Rachel Tate uptoTate

      4 years 11 months ago
      Dr. Crow's #StateoftheArt lecture revealed that BEL may be best used in pts with < 2 years and SLEDAI >10 based on the study from Gatto, M et al from 2020. Does this change how you will use BEL in your practice? #ACR20 @RheumNow
      RT @drdavidliew: We were always taught that rheumatic disease ILD is v bad in pregnancy.

      Fetal outcomes are def bad in

      David Liew drdavidliew

      4 years 11 months ago
      We were always taught that rheumatic disease ILD is v bad in pregnancy. Fetal outcomes are def bad in severe ILD, but no maternal deaths/few Cx. May not need to avoid pregnancy/electively terminate! Largest-to-date cohort @dukemedicine n=94 @drbags71 #ACR20 ABST1446 @RheumNow https://t.co/E7BDHn8KJb
      RT @RHEUMarampa: This study identified novel RFs for RA-ILD:
      Obesity
      ⬆CRP(≥10mg/L)
      Poor function(MDHAQ ≥1)
      High e

      sheila RHEUMarampa

      4 years 11 months ago
      This study identified novel RFs for RA-ILD: Obesity ⬆CRP(≥10mg/L) Poor function(MDHAQ ≥1) High education 30py smoking hx assoc'd w/⬆ RA-ILD risk Do u counsel RA pts on smoking cessation & lifestyle change? @Rheumnow #ACR20 abs1198 #ACRbest @jeffsparks https://t.co/jvZ26n8k5p
      RT @synovialjoints: Another interesting paper looking at screening of AxSpA in AAU patients with chronic back pain. At l

      Dr. Antoni Chan synovialjoints

      4 years 11 months ago
      Another interesting paper looking at screening of AxSpA in AAU patients with chronic back pain. At least 64% patients had confirmed or suspected AxSpA @RheumNow #ACR20 Abstr#1306
      RT @ejdein1: John Stone: "The HISTORY is the Rheumatologist's scalpel." TA bx is not gold standard in diagnosis, as not

      Eric Dein ejdein1

      4 years 11 months ago
      John Stone: "The HISTORY is the Rheumatologist's scalpel." TA bx is not gold standard in diagnosis, as not fully sensitive. @RheumNow #ACR20.
      RT @Janetbirdope: Nurses Health Study results - live healthy &amp; 40% less chance of Getting #SLE #lupus. Not an easy r

      Janet Pope Janetbirdope

      4 years 11 months ago
      Nurses Health Study results - live healthy & 40% less chance of Getting #SLE #lupus. Not an easy recipe - diet in top 40%, never smoking, regular exercise, modest ETOH, normal BMI. Abstr#1473 Maybe that is why SLE is in the rise Abstr#0274 @RheumNow @CRASCRRheum https://t.co/qYCkYC6Mqq
      ×